Overview
The clinical effect of blockers in human heart failure is quite variable. Some patients show marked improvement in heart function whilst others show marginal or no improvement. In patients with non-ischemic cardiomyopathy treated with carvedilol we found that the Arg389Gly-1 adrenoceptor polymorphism predicts improvement in left ventricular ejection fraction.
- Research leader
- Organisational unit
- Lead unit Faculty of Science and Technology
- Research area
- Pharmacy